These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4291164)

  • 1. Interference with fibrin stabilization by polymyxin B sulfate.
    Marshall FN; Massad EN
    Proc Soc Exp Biol Med; 1967 Jun; 125(2):420-3. PubMed ID: 4291164
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug induced inhibition of fibrin stabilization.
    Marshall FN; Capps JC; Massad EN
    Thromb Diath Haemorrh; 1968 Jul; 19(3):601-2. PubMed ID: 4303484
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of polymyxin B and E (colistin) on blood coagulation, thrombocyte function, and fibrin structure (author's transl)].
    Klingemann HG; Egbring R; Kaffarnik H
    Arzneimittelforschung; 1980; 30(10):1719-21. PubMed ID: 6254544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the physical properties of fibrin clots during desmofibrinogenesis.
    Buluk K; Zuch A; Olbromski J
    Arch Immunol Ther Exp (Warsz); 1968; 16(1):12-23. PubMed ID: 5651517
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-linking of salmon fibrinogen and fibrin by factor XIII and transglutaminase.
    Murtaugh PA; Halver JE; Gladner JA
    Biochem Biophys Res Commun; 1973 Oct; 54(3):849-55. PubMed ID: 4148128
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cysteine and hemolyzed erythrocytes on the properties of clotted fibrin.
    Ostrowski L
    Pol Med J; 1966; 5(6):1197-214. PubMed ID: 5973024
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S; Markiewicz M; Nath N
    J Lab Clin Med; 1973 May; 81(5):641-50. PubMed ID: 4698655
    [No Abstract]   [Full Text] [Related]  

  • 8. The action of Arvin on Fibrin Stabilizing Factor (factor 13).
    Barlow GH; Holleman WH; Lorand L
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):39-42. PubMed ID: 5535658
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro properties of mixtures of fibrin seal and antibiotics.
    Redl H; Schlag G; Stanek G; Hirschl A; Seelich T
    Biomaterials; 1983 Jan; 4(1):29-32. PubMed ID: 6601497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLASMA FIBRIN STABILIZING FACTOR ACTIVITY IN VARIOUS DISEASES.
    NUSSBAUM M; MORSE BS
    Blood; 1964 May; 23():669-78. PubMed ID: 14142505
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic and toxicologic studies with the polymyxins. II. Comparative pharmnacologic studies of the sulfate and methanesulfonate salts of polymyxin B and colistin in dogs.
    al-Khayyat AA; Aronson AL
    Chemotherapy; 1973; 19(2):82-97. PubMed ID: 4357724
    [No Abstract]   [Full Text] [Related]  

  • 13. Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen.
    Shen L; Lorand L
    J Clin Invest; 1983 May; 71(5):1336-41. PubMed ID: 6853717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral contraceptives on fibrin-clot stabilization.
    Shanberge JN; Tanaka K; Gruhl MC; Ikemori R; Inoshita K
    Ann N Y Acad Sci; 1972 Dec; 202():220-9. PubMed ID: 4508925
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental models of defibrination states.
    Lipiński B
    Pol Med J; 1971; 10(3):619-26. PubMed ID: 4256509
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrin stabilizing factor factor 8).
    Alami SY; Hampton JW; Race GJ; Speer RJ
    Am J Med; 1968 Jan; 44(1):1-7. PubMed ID: 4865195
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of cysteine and hemolyzed erythrocytes on the properties of clotted fibrin].
    Ostrowski L
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1964; 10():118-35. PubMed ID: 4955710
    [No Abstract]   [Full Text] [Related]  

  • 18. A procoagulant from human postpartum serum. Effects of coagulation and hemodynamics in dogs.
    Nordström S; Olsson P; Teger-Nilsson AC; Zetterqvist E
    Acta Physiol Scand; 1969 Aug; 76(4):399-405. PubMed ID: 5388053
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of bypass surgery on coagulation-sensitive clotting factors.
    Woods JE; Kirklin JW; Owen CA; Thompson JH; Taswell HF
    Mayo Clin Proc; 1967 Nov; 42(11):724-35. PubMed ID: 6053800
    [No Abstract]   [Full Text] [Related]  

  • 20. [Participation of sialic acid residue in the fibrinogen-fibrin conversion by thrombin].
    Akihama S; Matsuda Y; Fukase T; Yamanaka A; Okude M
    Yakugaku Zasshi; 1995 Jul; 115(7):537-42. PubMed ID: 7562401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.